Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence

HIGHLIGHTS

• who: Lei Zhou from the DepartmentMedical University have published the research work: Photobiomodulation therapy retarded axial length growth in children with myopia: evidence from a 12-month randomized controlled trial evidence, in the Journal: Scientific Reports Scientific Reports
• what: After randomization, in the absence of additional intervention, the main reason for dropout in the control group was unacceptable (only SVS), whereas the main reason for dropout in the PBM group was understandable, as it was due to the uncertain harm of this new therapy. The COVID-19 pandemic was the main reason for the other . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.